SKAN Group AG (LTS:0SKN) Notes Receivable: CHF0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0SKN SKAN Group AG LTS:0SKN
82 GF Score
Price CHF57.97
GF Value CHF86.93
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is SKAN Group AG Notes Receivable?

SKAN Group AG LTS:0SKN -2.31% 82 Notes Receivable is CHF0.0 Mil as of Dec. 2025. GuruFocus rates LTS:0SKN with a GF Score™ of 82/100 and a GF Value™ of CHF86.93 (Significantly Undervalued). The stock has 6 warning signs investors should review.

SKAN Group AG's Notes Receivable for the quarter that ended in Dec. 2025 was CHF0.0 Mil.

SKAN Group AG Notes Receivable Historical Data

* Premium members only.

The historical data trend for SKAN Group AG's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SKAN Group AG Notes Receivable Chart

SKAN Group AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

SKAN Group AG Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LTS:0SKN
82GF Score
SKAN Group AG LTS:0SKN
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SKAN Group AG Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of CHF0.0 Mil mean?
SKAN Group AG (LTS:0SKN) has a Notes Receivable of CHF0.0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on SKAN Group AG and its competitors.
Is SKAN Group AG's Notes Receivable too high?
SKAN Group AG's current Notes Receivable is CHF0.0 Mil. Overall, SKAN Group AG has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's Notes Receivable compare to ISRG and BDX?
SKAN Group AG's Notes Receivable of CHF0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on SKAN Group AG and its competitors. SKAN Group AG's current Notes Receivable is CHF0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (LTS:0SKN) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF86.93, compared to a current price of CHF57.97 — trading 33.3% below its estimated fair value. The current Notes Receivable is CHF0.0 Mil. SKAN Group AG's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For SKAN Group AG (LTS:0SKN), the current Notes Receivable is CHF0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SKAN Group AG (LTS:0SKN) Overvalued in 2026?

Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued. The current stock price of CHF57.97 is trading 33.3% below its estimated GF Value™ of CHF86.93. GuruFocus considers SKAN Group AG to be Significantly Undervalued.

Key valuation signals for LTS:0SKN:

  • Notes Receivable: CHF0.0 Mil
  • GF Value™: CHF86.93 vs. price of CHF57.97 (33.3% below fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the LTS:0SKN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SKAN Group AG Business Description

Address Kreuzstrasse 5, Allschwil, CHE, 4123
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
82GF Score

Get the complete analysis for LTS:0SKN

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF57.97
Price
CHF86.93
GF Value